Infections in primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis
Open Access
- 3 September 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 8 (5) , 163-178
Abstract
Purpose: Primary sclerosing cholangitis (PSC) is a cholestatic liver disease that frequently coexists with inflammatory bowel disease (IBD). The risk of infections in patients with concurrent PSC-IBD remains unclear. The aim of this study was to identify the event rate of infections and associated risk factors in PSC-IBD patients. Methods: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from inception to September 12, 2024 for studies examining event rate or risk factors for infection in patients with PSC-IBD. The primary outcome was the event rate of all-cause and site-specific infections as well as infection-related mortality. The secondary outcome was risk factors for infection. Random-effects models were used to calculate pooled odds ratios (OR) with 95% confidence intervals (CI) comparing the event rate of all-cause infections in PSC-IBD patients to those with just PSC and just IBD. I2 values more than 50% suggested substantial heterogeneity. Results: Eighty-one studies were included. The pooled event rate of all-cause infections in patients with PSC-IBD was 25.1% (95% CI, 17.0%-33.2%, I2 = 99.2%). PSC-IBD patients had significantly increased odds of all-cause infection (OR 3.67, 95% CI, 2.07-6.52, I2 = 41.9%), sepsis (OR 3.35, 95% CI, 2.29-4.91, I2 = 9.1%), and infection-related mortality (OR 11.25, 95% CI, 2.03-62.37, I2 = 0) compared to those with IBD but not those with PSC. Conclusion: Patients with PSC-IBD appear to be at increased risk of all-cause infection, sepsis, and mortality compared to those with IBD alone.Keywords
This publication has 93 references indexed in Scilit:
- Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing CholangitisLiver Transplantation, 2020
- Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipientsLiver Transplantation, 2014
- Risk of Colonic Neoplasia After Liver Transplantation for Primary Sclerosing CholangitisInflammatory Bowel Diseases, 2012
- Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in KoreaInflammatory Bowel Diseases, 2011
- Ileal pouch–anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitisBritish Journal of Surgery, 2008
- Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitisHepatology, 2008
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Inflammatory bowel disease in primary sclerosing cholangitis: An analysis of patients undergoing liver transplantationBritish Journal of Surgery, 1995
- Colectomy in patients with inflammatory bowel disease and primary sclerosing cholangitisDiseases of the Colon & Rectum, 1994
- Does Primary Sclerosing Cholangitis Occurring in Association With Inflammatory Bowel Disease Differ From That Occurring in the Abssence of Inflammatory Bowel Disease? A Study of Sixty–Six SubjectsHepatology, 1990